{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:51:22Z","timestamp":1761519082302},"reference-count":22,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":639,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ANZ J Surg"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1111\/ans.12388","type":"journal-article","created":{"date-parts":[[2013,12,2]],"date-time":"2013-12-02T05:52:18Z","timestamp":1385963538000},"page":"924-928","source":"Crossref","is-referenced-by-count":16,"title":["Relevance of the American College of Surgeons Oncology Group Z0011 Trial to breast cancer in the Australian setting"],"prefix":"10.1111","volume":"83","author":[{"given":"Nicholas K.","family":"Ngui","sequence":"first","affiliation":[{"name":"Westmead Breast Cancer Institute; Westmead Hospital; Sydney New South Wales Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth E.","family":"Elder","sequence":"additional","affiliation":[{"name":"Westmead Breast Cancer Institute; Westmead Hospital; Sydney New South Wales Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Upali W.","family":"Jayasinghe","sequence":"additional","affiliation":[{"name":"Westmead Breast Cancer Institute; Westmead Hospital; Sydney New South Wales Australia"},{"name":"Centre for Primary Health Care and Equity; University of New South Wales; Sydney New South Wales Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"French","sequence":"additional","affiliation":[{"name":"Westmead Breast Cancer Institute; Westmead Hospital; Sydney New South Wales Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,12,2]]},"reference":[{"key":"10.1111\/ans.12388-BIB0001|ans12388-cit-0001","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/SLA.0b013e3181f08f32","article-title":"Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases","volume":"252","author":"Giuliano","year":"2010","journal-title":"Ann. Surg."},{"key":"10.1111\/ans.12388-BIB0002|ans12388-cit-0002","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.2011.90","article-title":"Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial","volume":"305","author":"Giuliano","year":"2011","journal-title":"JAMA"},{"key":"10.1111\/ans.12388-BIB0003|ans12388-cit-0003","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1245\/s10434-008-0229-z","article-title":"Sentinel-lymph-node-based management or routine axillary clearance? One-year outcomes of sentinel node biopsy versus axillary clearance (SNAC): a randomized controlled surgical trial","volume":"16","author":"Gill","year":"2009","journal-title":"Ann. Surg. Oncol."},{"key":"10.1111\/ans.12388-BIB0004|ans12388-cit-0004","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/jnci\/djj158","article-title":"Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial","volume":"98","author":"Mansel","year":"2006","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1111\/ans.12388-BIB0005|ans12388-cit-0005","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","article-title":"Sentinel-lymph node resection compared with conventional axillary-lymph node dissection in clinically node-negative patients with breast cancer: overall survival findings from NSABP B-32 randomised phase 3 trial","volume":"11","author":"Krag","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1111\/ans.12388-BIB0006|ans12388-cit-0006","unstructured":"National Breast and Ovarian Cancer Centre Recommendations for use of sentinel node biopsy in early (operable) breast cancer 2010"},{"key":"10.1111\/ans.12388-BIB0007|ans12388-cit-0007","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1245\/ASO.2003.04.022","article-title":"Preliminary outcome analysis in patients with breast cancer and a positive sentinel lymph node who declined axillary dissection","volume":"10","author":"Fant","year":"2003","journal-title":"Ann. Surg. Oncol."},{"key":"10.1111\/ans.12388-BIB0008|ans12388-cit-0008","doi-asserted-by":"crossref","first-page":"S343","DOI":"10.1245\/s10434-010-1253-3","article-title":"Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive breast cancer patients: experience from the SEER database","volume":"17","author":"Yi","year":"2010","journal-title":"Ann. Surg. Oncol."},{"key":"10.1111\/ans.12388-BIB0009|ans12388-cit-0009","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1200\/JCO.2008.19.5750","article-title":"Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer","volume":"27","author":"Bilimoria","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1111\/ans.12388-BIB0010|ans12388-cit-0010","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/cncr.22847","article-title":"Low locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection","volume":"110","author":"Hwang","year":"2007","journal-title":"Cancer"},{"key":"10.1111\/ans.12388-BIB0011|ans12388-cit-0011","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.1245\/s10434-012-2490-4","article-title":"Axillary recurrence after a tumor-positive sentinel lymph node biopsy without axillary treatment: a review of the literature","volume":"19","author":"Francissen","year":"2012","journal-title":"Ann. Surg. Oncol."},{"key":"10.1111\/ans.12388-BIB0012|ans12388-cit-0012","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1001\/archsurg.138.1.52","article-title":"Axillary dissection is not required for all patients with breast cancer and positive sentinel nodes","volume":"138","author":"Guenther","year":"2003","journal-title":"Arch. Surg."},{"key":"10.1111\/ans.12388-BIB0013|ans12388-cit-0013","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s10434-004-1164-2","article-title":"Axillary recurrence after sentinel node biopsy","volume":"12","author":"Jeruss","year":"2005","journal-title":"Ann. Surg. Oncol."},{"key":"10.1111\/ans.12388-BIB0014|ans12388-cit-0014","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1503\/cjs.036011","article-title":"Axillary dissection versus no axillary dissection in women with invasive breast cancer and sentinel node metastases","volume":"55","author":"Latosinsky","year":"2012","journal-title":"Can. J. Surg."},{"key":"10.1111\/ans.12388-BIB0015|ans12388-cit-0015","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1470-2045(13)70035-4","article-title":"Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial","volume":"14","author":"Galimberti","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1111\/ans.12388-BIB0016|ans12388-cit-0016","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/01.sla.0000250439.86020.85","article-title":"A declining rate of completion axillary dissection in sentinel lymph node-positive breast cancer patients is associated with the use of a multivariate nomogram","volume":"245","author":"Park","year":"2007","journal-title":"Ann. Surg."},{"key":"10.1111\/ans.12388-BIB0017|ans12388-cit-0017","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/SLA.0b013e31823dc616","article-title":"Regional recurrence in breast cancer patients with sentinel node micrometastases and isolated tumor cells","volume":"255","author":"Pepels","year":"2012","journal-title":"Ann. Surg."},{"key":"10.1111\/ans.12388-BIB0018|ans12388-cit-0018","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa0904832","article-title":"Micrometastases or isolated tumor cells and the outcome of breast cancer","volume":"361","author":"De Boer","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1111\/ans.12388-BIB0019|ans12388-cit-0019","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1245\/s10434-011-1593-7","article-title":"Multidisciplinary considerations in the implementation of the findings from the American College of Surgeons Oncology Group (ACOSOG) Z0011 study: a practice-changing trial","volume":"18","author":"Caudle","year":"2011","journal-title":"Ann. Surg. Oncol."},{"issue":"Suppl. 1","key":"10.1111\/ans.12388-BIB0020|ans12388-cit-0020","first-page":"24","article-title":"The clinical impact of the American College of Surgeons Oncology Group z-0011 Trial- results from the BreastSurgANZ National Breast Cancer Audit","volume":"82","author":"Ainsworth","year":"2012","journal-title":"ANZ J. Surg."},{"key":"10.1111\/ans.12388-BIB0021|ans12388-cit-0021","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/01.sla.0000137130.23530.19","article-title":"The risk of axillary relapse after sentinel node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures","volume":"240","author":"Naik","year":"2004","journal-title":"Ann. Surg."},{"key":"10.1111\/ans.12388-BIB0022|ans12388-cit-0022","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa020128","article-title":"Twenty-five-year follow up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation","volume":"347","author":"Fisher","year":"2002","journal-title":"N. Engl. J. Med."}],"container-title":["ANZ Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fans.12388","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ans.12388\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T08:12:45Z","timestamp":1647591165000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ans.12388"}},"subtitle":["Relevance of Z0011 trial to breast cancer in Australia"],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":22,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"URL":"https:\/\/doi.org\/10.1111\/ans.12388","relation":{},"ISSN":["1445-1433"],"issn-type":[{"value":"1445-1433","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}